GlassScriptPhysician profile
Glenn L Goldstein
NPI 1346336575
$2,625.99
in general payments reported to CMS, 2019-2025
23 companies · $41.64 in 2025
The $41.64 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $120 · 2021: $1,019 · 2022: $377 · 2023: $187 · 2024: $214 · 2025: $41.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317 · Gift: $81.81 · Education: $43.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.26 |
| Gift | $81.81 |
| Education | $43.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $498.66 | 2020-2023 | |
| Novo Nordisk INC | $349.56 | 2019-2021 | |
| Braintree Laboratories, INC. | $323.19 | 2020-2024 | Suflave, Sutab |
| Bayer Healthcare Pharmaceuticals INC. | $243.68 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $203.19 | 2019-2025 | Gattex |
| Merck Sharp & Dohme LLC | $200.51 | 2020-2025 | Zerbaxa, Bridion |
| Mallinckrodt Enterprises LLC | $145.32 | 2019 | |
| Abbvie INC. | $143.33 | 2019-2024 | |
| Pfizer INC. | $138.09 | 2019 | |
| Ethicon US, LLC | $57.78 | 2019-2023 | Contour, Stratafix, Echelon; Endopath |
| Solventum Corporation | $54.69 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Paratek Pharmaceuticals, INC. | $45.89 | 2022 | |
| Cook Medical LLC | $34.77 | 2019-2024 | Zilver Ptx |
| Mimedx Group, INC. | $29.27 | 2024 | |
| Aroa Biosurgery Incorporated | $28.27 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $22.96 | 2023 | |
| Mallinckrodt Hospital Products INC. | $22.52 | 2021 | |
| Tela Bio, INC. | $15.51 | 2021 | |
| Celgene Corporation | $15.07 | 2022 | |
| Thd America, INC. | $14.82 | 2023 | |
| Convatec INC. | $14.47 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.09 | 2022 | |
| Baudax Bio INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.